WO2022255251A1 - 二層培養基材 - Google Patents
二層培養基材 Download PDFInfo
- Publication number
- WO2022255251A1 WO2022255251A1 PCT/JP2022/021748 JP2022021748W WO2022255251A1 WO 2022255251 A1 WO2022255251 A1 WO 2022255251A1 JP 2022021748 W JP2022021748 W JP 2022021748W WO 2022255251 A1 WO2022255251 A1 WO 2022255251A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- culture
- tissue
- cells
- layer
- intestinal epithelial
- Prior art date
Links
- 239000000758 substrate Substances 0.000 title claims abstract description 152
- 238000013334 tissue model Methods 0.000 claims abstract description 98
- 239000007788 liquid Substances 0.000 claims abstract description 62
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 50
- 229920002678 cellulose Polymers 0.000 claims abstract description 47
- 239000001913 cellulose Substances 0.000 claims abstract description 47
- 238000004519 manufacturing process Methods 0.000 claims abstract description 44
- 229920001410 Microfiber Polymers 0.000 claims abstract description 25
- 239000003658 microfiber Substances 0.000 claims abstract description 25
- 239000012528 membrane Substances 0.000 claims abstract description 19
- 229920000642 polymer Polymers 0.000 claims abstract description 18
- 210000004027 cell Anatomy 0.000 claims description 95
- 210000000981 epithelium Anatomy 0.000 claims description 72
- 230000000968 intestinal effect Effects 0.000 claims description 63
- 210000001519 tissue Anatomy 0.000 claims description 52
- 238000001035 drying Methods 0.000 claims description 29
- 230000000694 effects Effects 0.000 claims description 27
- 238000000034 method Methods 0.000 claims description 26
- 210000002490 intestinal epithelial cell Anatomy 0.000 claims description 18
- 210000004379 membrane Anatomy 0.000 claims description 15
- 238000009987 spinning Methods 0.000 claims description 13
- 238000001523 electrospinning Methods 0.000 claims description 12
- 238000012258 culturing Methods 0.000 claims description 11
- 230000004888 barrier function Effects 0.000 claims description 10
- 210000002919 epithelial cell Anatomy 0.000 claims description 10
- 239000003960 organic solvent Substances 0.000 claims description 9
- 102000004190 Enzymes Human genes 0.000 claims description 8
- 108090000790 Enzymes Proteins 0.000 claims description 8
- 210000002615 epidermis Anatomy 0.000 claims description 8
- 210000000056 organ Anatomy 0.000 claims description 8
- 230000003843 mucus production Effects 0.000 claims description 7
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 6
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 6
- 230000006862 enzymatic digestion Effects 0.000 claims description 6
- 210000000110 microvilli Anatomy 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims description 3
- 238000010030 laminating Methods 0.000 claims description 3
- 239000012780 transparent material Substances 0.000 claims 1
- 238000004113 cell culture Methods 0.000 abstract description 51
- 238000010521 absorption reaction Methods 0.000 abstract description 10
- 230000003287 optical effect Effects 0.000 abstract description 8
- 238000000338 in vitro Methods 0.000 abstract description 3
- 230000002123 temporal effect Effects 0.000 abstract description 2
- 239000003125 aqueous solvent Substances 0.000 abstract 1
- 238000009736 wetting Methods 0.000 abstract 1
- 239000010410 layer Substances 0.000 description 204
- 229920002301 cellulose acetate Polymers 0.000 description 100
- 229920000159 gelatin Polymers 0.000 description 69
- 108010010803 Gelatin Proteins 0.000 description 68
- 239000008273 gelatin Substances 0.000 description 68
- 235000019322 gelatine Nutrition 0.000 description 68
- 235000011852 gelatine desserts Nutrition 0.000 description 68
- 239000000835 fiber Substances 0.000 description 65
- 239000000463 material Substances 0.000 description 47
- 238000009630 liquid culture Methods 0.000 description 43
- 239000000243 solution Substances 0.000 description 35
- 238000002474 experimental method Methods 0.000 description 19
- 210000003097 mucus Anatomy 0.000 description 18
- 239000011521 glass Substances 0.000 description 14
- 239000002609 medium Substances 0.000 description 13
- 239000000126 substance Substances 0.000 description 13
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 12
- 229910052710 silicon Inorganic materials 0.000 description 11
- 239000010703 silicon Substances 0.000 description 11
- 102000004328 Cytochrome P-450 CYP3A Human genes 0.000 description 10
- 108010081668 Cytochrome P-450 CYP3A Proteins 0.000 description 10
- 239000001963 growth medium Substances 0.000 description 10
- 108090000915 Aminopeptidases Proteins 0.000 description 9
- 102000004400 Aminopeptidases Human genes 0.000 description 9
- 238000007654 immersion Methods 0.000 description 9
- 238000011160 research Methods 0.000 description 9
- KPKZJLCSROULON-QKGLWVMZSA-N Phalloidin Chemical compound N1C(=O)[C@@H]([C@@H](O)C)NC(=O)[C@H](C)NC(=O)[C@H](C[C@@](C)(O)CO)NC(=O)[C@H](C2)NC(=O)[C@H](C)NC(=O)[C@@H]3C[C@H](O)CN3C(=O)[C@@H]1CSC1=C2C2=CC=CC=C2N1 KPKZJLCSROULON-QKGLWVMZSA-N 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- 238000010586 diagram Methods 0.000 description 8
- 150000004676 glycans Chemical class 0.000 description 8
- 238000001727 in vivo Methods 0.000 description 8
- 229920001282 polysaccharide Polymers 0.000 description 8
- 239000005017 polysaccharide Substances 0.000 description 8
- 238000010186 staining Methods 0.000 description 8
- 102000007469 Actins Human genes 0.000 description 7
- 108010085238 Actins Proteins 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 239000002953 phosphate buffered saline Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 6
- 229930040373 Paraformaldehyde Natural products 0.000 description 5
- 229920002866 paraformaldehyde Polymers 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000003068 static effect Effects 0.000 description 5
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 229920000936 Agarose Polymers 0.000 description 4
- 108010049990 CD13 Antigens Proteins 0.000 description 4
- 229920002101 Chitin Polymers 0.000 description 4
- 229920001661 Chitosan Polymers 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 229920002307 Dextran Polymers 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- 239000000020 Nitrocellulose Substances 0.000 description 4
- 108010009711 Phalloidine Proteins 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 229920000954 Polyglycolide Polymers 0.000 description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 229920001525 carrageenan Polymers 0.000 description 4
- 239000000679 carrageenan Substances 0.000 description 4
- 235000010418 carrageenan Nutrition 0.000 description 4
- 229940113118 carrageenan Drugs 0.000 description 4
- 230000021164 cell adhesion Effects 0.000 description 4
- 239000006285 cell suspension Substances 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 239000011243 crosslinked material Substances 0.000 description 4
- 238000012136 culture method Methods 0.000 description 4
- 210000004748 cultured cell Anatomy 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 238000010894 electron beam technology Methods 0.000 description 4
- 210000001339 epidermal cell Anatomy 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 238000010191 image analysis Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229920001220 nitrocellulos Polymers 0.000 description 4
- 238000010899 nucleation Methods 0.000 description 4
- 229920000117 poly(dioxanone) Polymers 0.000 description 4
- 229920000747 poly(lactic acid) Polymers 0.000 description 4
- 229920002401 polyacrylamide Polymers 0.000 description 4
- 239000004584 polyacrylic acid Substances 0.000 description 4
- 229920001610 polycaprolactone Polymers 0.000 description 4
- 239000004632 polycaprolactone Substances 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 239000004633 polyglycolic acid Substances 0.000 description 4
- 239000004626 polylactic acid Substances 0.000 description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000004627 regenerated cellulose Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 description 4
- 229920003169 water-soluble polymer Polymers 0.000 description 4
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 4
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 description 3
- 239000012109 Alexa Fluor 568 Substances 0.000 description 3
- 229920004890 Triton X-100 Polymers 0.000 description 3
- 239000012736 aqueous medium Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 102000038379 digestive enzymes Human genes 0.000 description 3
- 108091007734 digestive enzymes Proteins 0.000 description 3
- 235000013376 functional food Nutrition 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 238000001878 scanning electron micrograph Methods 0.000 description 3
- 239000002356 single layer Substances 0.000 description 3
- 238000004544 sputter deposition Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- RBFQJDQYXXHULB-UHFFFAOYSA-N arsane Chemical compound [AsH3] RBFQJDQYXXHULB-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000007876 drug discovery Methods 0.000 description 2
- 230000036267 drug metabolism Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000003517 fume Substances 0.000 description 2
- 238000004020 luminiscence type Methods 0.000 description 2
- 238000001755 magnetron sputter deposition Methods 0.000 description 2
- 230000000873 masking effect Effects 0.000 description 2
- 230000004660 morphological change Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 230000008823 permeabilization Effects 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002834 transmittance Methods 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 229960001005 tuberculin Drugs 0.000 description 2
- TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 description 1
- 235000008645 Chenopodium bonus henricus Nutrition 0.000 description 1
- 244000138502 Chenopodium bonus henricus Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical class CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 239000012901 Milli-Q water Substances 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000007611 bar coating method Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- PXFUDSMGEYRNNC-LURJTMIESA-N l-alanine-4-nitroanilide Chemical compound C[C@H](N)C(=O)NC1=CC=C([N+]([O-])=O)C=C1 PXFUDSMGEYRNNC-LURJTMIESA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229920006298 saran Polymers 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001578 tight junction Anatomy 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M3/00—Tissue, human, animal or plant cell, or virus culture apparatus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
Definitions
- the present invention relates to a two-layer culture substrate for cell culture and a biological tissue model produced using the two-layer culture substrate.
- the present invention uses a two-layer culture substrate consisting of a porous cellulose derivative membrane and polymer microfibers, which enables cell culture and real-time observation at the air-liquid interface, and the two-layer culture substrate. It relates to a biological tissue model to be produced.
- Non-Patent Document 1 Non-Patent Document 1
- the culture substrate itself such as its small culture area and high cost, and the problem that the structure and function of the intestinal model tissue are insufficient compared to living tissue (two-dimensional planar structure without villous processes, mucous matrix production, etc.). , long time required for differentiation/maturation, etc.).
- Non-Patent Document 2 a cost-effective two-layer culture substrate by electrospinning gelatin-based microfibers (upper layer) onto commercially available paper (lower layer) (Non-Patent Document 2).
- the culture solution is held in the paper layer, and the culture solution is supplied from the basal side of the cells adhered to the upper fiber layer through the gaps between the microfibers, and the air-liquid interface culture is performed while exposing the cells to the gas phase.
- Non-Patent Document 3 a system to do this.
- intestinal epithelial cells When intestinal epithelial cells are cultured at the air-liquid interface on this two-layer culture substrate, (i) they form a three-dimensional villus structure similar to that of living organisms, and (ii) they have excellent mucus-producing ability, as well as barrier function, digestion, and drug metabolism. It is possible to prepare an intestinal epithelial tissue model that has functions and (iii) has the advantage of being differentiated and matured in a short period of time (10 to 12 days).
- the present invention by culturing intestinal epithelial cells, it is possible to observe the cultured cells over time with an optical microscope, while forming a villus-like three-dimensional structure like living tissue, and producing mucus and various enzyme activities.
- a two-layer culture substrate capable of producing an intestinal epithelial tissue model having the function of and a method for producing the same, and an intestinal epithelial tissue model produced using the two-layer substrate and a method for producing the same do.
- the present invention provides a new two-layer culture substrate that combines a porous cellulose derivative membrane and polymer microfibers by imparting porosity to the cellulose membrane under predetermined conditions.
- the two-layer culture substrate becomes transparent when it is wetted with an aqueous medium such as a culture solution. observation is possible.
- the present invention provides a transparent two-layer substrate for culturing cells and/or tissues, comprising a porous cellulose derivative membrane having optical transparency under wet conditions and polymer microfibers spun and laminated. I will provide a.
- the culture may be air-liquid interface culture.
- the cells are intestinal epithelial cells, epithelial cells of other tissues or organs, or cells constituting the epidermis, and the tissue is intestinal epithelial tissue, other epithelial tissue, or epidermal tissue. Sometimes.
- the material of the porous cellulose derivative film may be selected from cellulose acetate, cellulose nitrate and regenerated cellulose.
- the polymeric microfiber material is gelatin, polysaccharide, collagen, polycaprolactone, polylactic acid, polyglycolic acid, poly-p-dioxanone, polyhydroxybutyric acid, trimethylene carbonate, poly Acrylic acid derivatives or polymethacrylic acid derivatives or copolymers thereof, or water-soluble polymers of polyvinyl alcohol, polyethylene oxide, polyacrylamide, polyvinylpyrrolidone, dextran or polyethylene glycol, or crosslinked materials thereof, or mixtures thereof may be selected from
- the polysaccharide may be cellulose, oxidized derivatives of cellulose, chitin, chitosan, agarose or carrageenan.
- the present invention (1) dissolving a cellulose derivative in an organic solvent to prepare an organic solvent solution of the cellulose derivative; (2) preparing a cellulose derivative film by coating the organic solvent solution of the cellulose derivative on a substrate and drying; (3) The cellulose derivative film is dried for a predetermined time, then immersed in hot water for a predetermined time, then immersed in cold water for a predetermined time, and then peeled off from the substrate to form a porous cellulose derivative film. preparing, and (4) spinning and laminating polymer microfibers on the porous cellulose derivative membrane by electrospinning; A method for producing a transparent two-layer substrate for cell and/or tissue culture, comprising:
- the drying time is 10 seconds at a temperature of 20 to 25 ° C.
- the hot water immersion time is 80 ° C. for 10 minutes
- the cold water immersion time is 20 to 25 ° C. for 60 minutes. may be.
- the cells may be intestinal epithelial cells, epithelial cells of other tissues or organs, or cells constituting the epidermis, and the tissue may be intestinal epithelial tissue, other epithelial tissue, or epidermal tissue. .
- the porous cellulose derivative may be selected from cellulose acetate, cellulose nitrate, and regenerated cellulose.
- the material of the polymer microfiber is gelatin, polysaccharide, collagen, polycaprolactone, polylactic acid, polyglycolic acid, poly-p-dioxanone, polyhydroxybutyric acid, trimethylene carbonate, polyacrylic acid derivative. or polymethacrylic acid derivatives or copolymers thereof, or water-soluble polymers of polyvinyl alcohol, polyethylene oxide, polyacrylamide, polyvinylpyrrolidone, dextran or polyethylene glycol, or crosslinked materials thereof, or mixtures thereof may occur.
- the polysaccharide may be cellulose, oxidized derivatives of cellulose, chitin, chitosan, agarose or carrageenan.
- the substrate may be a glass substrate.
- the present invention provides a biological tissue model produced by using the transparent two-layer substrate and culturing cells and/or tissues on polymer microfibers.
- the culture may be air-liquid interface culture.
- the cells are intestinal epithelial cells or epidermal cells
- the tissue is intestinal epithelial tissue or epidermal tissue
- the biological tissue model is selected from an intestinal epithelial tissue model or an epidermal tissue model, respectively.
- the intestinal epithelial tissue model has villous projection structure, microvillus structure, digestive enzyme activity, drug-metabolizing enzyme activity, mucus production ability, barrier function and/or alkaline phosphatase (ALP) expression. It may be a biological tissue model.
- the present invention provides a method for producing a biological tissue model using the transparent two-layer base material and culturing cells and/or tissues on polymer microfibers.
- the culture may be air-liquid interface culture.
- the cells are intestinal epithelial cells or epidermal cells
- the tissue is intestinal epithelial tissue or epidermal tissue
- the biological tissue model is an intestinal epithelial tissue model or epidermal tissue model, respectively.
- the intestinal epithelial tissue model may have villus structure, microvillus structure, digestive enzyme activity, drug metabolizing enzyme activity and/or mucus production ability.
- a culture system using the transparent two-layer base material of the present invention can produce a large-area base material.
- the processability of this two-layer culture substrate is also excellent, and a large substrate can be cut into appropriate sizes for use.
- application to the culture of various epithelial cells and the construction of living tissue can also be expected.
- These biological tissue models can be applied and developed as tissue models for evaluation of absorption and metabolism in drug discovery and functional foods, and tissues for transplantation therapy.
- CA Film P cellulose acetate film
- FIG. 10 is a photographic diagram showing the results of examining the stability in an aqueous medium of the fiber diameter of the two-layer base material of CA Film P.
- FIG. 2 is a photographic diagram of Caco-2 cells statically cultured in liquid using the transparent two-layer base material of the present invention and observed with a phase-contrast microscope until 21 days after the start of culture (Day 21).
- FIG. 10 is a photographic diagram showing fluorescence microscope observation images of culture samples observed up to 21 days (Day 21) after Caco-2 cells were statically cultured in liquid using the transparent two-layer base material of the present invention. Nuclei were stained with Hoechst 33342 and actin with Alexa Fluor 568 phalloidin.
- FIG. 10 is a photographic diagram showing fluorescence microscope observation images of culture samples observed up to 21 days (Day 21) after Caco-2 cells were statically cultured in liquid using the transparent two-layer base material of the present invention. Nuclei were stained with Hoechst 33342 and actin with Alexa Fluor 568 phalloidin.
- FIG. 2 is a photographic diagram showing phase-contrast images of cultured cells and/or tissue samples observed over time until 21 days (Day 21) after Caco-2 cells were cultured at the air-liquid interface using the transparent two-layer base material of the present invention. 10 days (Day 10), 12 days (Day 12) and 21 days after Caco-2 cells were cultured at the air-liquid interface by changing the amount of solution for spinning gelatin fibers on the two-layer substrate of the present invention from 1.5 to 3.0 mL.
- Fig. 2 shows scanning microscope (SEM) observation images of samples obtained by air-liquid culture of a two-layer base material of a CA film P layer and a gelatin fiber layer.
- FIG. 4 is a graph showing changes in ANPEP activity when Caco-2 cells are submerged or air-liquid cultured using the two-layer base material and cell culture insert of the present invention.
- two-layer substrate in gas-liquid indicates the case of performing air-liquid culture using the two-layer substrate of the present invention
- two-layer substrate in liquid indicates the case of using the two-layer substrate of the present invention.
- FIG. 3 is a diagram showing changes in CYP3A4 activity when Caco-2 cells are submerged or air-liquid cultured using the two-layer base material and cell culture insert of the present invention.
- two-layer substrate in gas-liquid indicates the case of performing air-liquid culture using the two-layer substrate of the present invention
- two-layer substrate in liquid indicates the case of using the two-layer substrate of the present invention.
- insert air-liquid indicates when air-liquid culture is performed using a cell culture insert
- insert submerged indicates when submerged culture is performed using a cell culture insert.
- Photographs of images observed with an optical microscope when Caco-2 cells are submerged or air-liquid cultured using the two-layer base material and cell culture insert of the present invention and stained with Alcian blue, which dyes mucus blue. represents a statue.
- two-layer substrate in gas-liquid indicates the case of performing air-liquid culture using the two-layer substrate of the present invention
- two-layer substrate in liquid indicates the case of using the two-layer substrate of the present invention.
- FIG. 10 is a diagram showing changes in mucus-producing ability over time when Caco-2 cells are submerged or air-liquid cultured using the two-layer base material and cell culture insert of the present invention.
- two-layer substrate in gas-liquid indicates the case of performing air-liquid culture using the two-layer substrate of the present invention
- two-layer substrate in liquid indicates the case of using the two-layer substrate of the present invention.
- insert air-liquid is when air-liquid culture is performed using a cell culture insert
- insert in liquid is when submerged culture is performed using a cell culture insert. It represents the time course of production.
- CA two-layer substrate gas-liquid is the case where air-liquid culture is performed using the two-layer substrate of the present invention
- CA two-layer substrate liquid is the two-layer substrate of the present invention.
- insert gas liquid is when submerged culture is performed using a cell culture insert
- insert submerged is when submerged culture is performed using a cell culture insert.
- Transparent Bilayer Substrates One embodiment of the present invention is a transparent substrate for cell and/or tissue culture in which polymeric microfibers are spun and laminated to a porous cellulose derivative membrane that is optically transparent under wet conditions. It is a two-layer substrate.
- the culture may preferably be air-liquid interface culture, but is not limited to air-liquid interface culture.
- the culture may be submerged culture.
- the transparent two-layer substrate of the present invention is a two-layer culture substrate consisting of a porous cellulose derivative membrane (lower layer) and polymer microfibers (upper layer).
- the culture solution is retained in the porous cellulose membrane, and the culture solution can be supplied from the basal side of the cells adhered to the upper fiber layer through the gaps between the microfibers.
- Air-liquid interface culture can be performed while As shown in the examples below, the properties of cultured cells and/or tissues differ depending on whether the culture is submerged or air-liquid. For example, alanine aminopeptidase (ANPEP) activity, which is a digestive enzyme, is higher in air-liquid culture than in submerged culture.
- ANPEP alanine aminopeptidase
- the two-layer culture substrate becomes a transparent two-layer substrate, making it possible to observe cultured cells with an optical microscope.
- the transparent two-layer base material of the present invention can be easily produced in a general laboratory facility if there is an electrospinning apparatus and simple equipment for film stretching.
- the transparent two-layer base material of the present invention is low in cost, and theoretically, it is possible to produce a large-area base material. In these respects, it is superior to commercially available cell culture inserts.
- the cells may be intestinal epithelial cells or epidermal cells
- the tissue may be intestinal epithelial tissue or epidermal tissue, but are not limited to these.
- biological tissue models such as intestinal epithelial tissue models and epidermal tissue models can be produced.
- the use of a transparent two-layer substrate allows continuous real-time microscopic observation during the culture period.
- the use of a two-layer base material consisting of a cellulose derivative film and polymer microfibers has improved the yield of biological tissue models. Tissue formation can be efficiently and stably performed.
- the material of the porous cellulose derivative film is selected from cellulose acetate, cellulose nitrate, and regenerated cellulose. Cellulose acetate is preferred.
- the polymer microfiber material is gelatin, polysaccharide, collagen, polycaprolactone, polylactic acid, polyglycolic acid, poly-p-dioxanone, polyhydroxybutyric acid, trimethylene carbonate, and polyacrylic acid.
- Derivatives or polymethacrylic acid derivatives or copolymers thereof, or water-soluble polymers of polyvinyl alcohol, polyethylene oxide, polyacrylamide, polyvinylpyrrolidone, dextran or polyethylene glycol, or crosslinked materials thereof, or mixtures thereof be done.
- Gelatin is preferred.
- polysaccharide in the transparent two-layer substrate are preferably cellulose, oxidized derivatives of cellulose, chitin, chitosan, agarose, or carrageenan.
- Another embodiment of the invention is a method of making a transparent two-layer substrate.
- the manufacturing method includes the steps of manufacturing a porous cellulose derivative membrane, and spinning and laminating polymeric microfibers on the porous cellulose derivative membrane by an electrospinning method.
- the method for producing the transparent two-layer substrate comprises: (1) dissolving a cellulose derivative in an organic solvent to prepare an organic solvent solution of the cellulose derivative; (2) preparing a cellulose derivative film by coating the organic solvent solution of the cellulose derivative on a substrate and drying; (3) The cellulose derivative film is dried for a predetermined time, then immersed in hot water for a predetermined time, then immersed in cold water for a predetermined time, and then peeled off from the substrate to form a porous cellulose derivative film. preparing, and (4) spinning polymeric microfibers onto the porous cellulose derivative membrane by electrospinning;
- a method for producing a transparent two-layer substrate for cell and/or tissue culture comprising:
- the coating method preferably includes, but is not limited to, a bar coating method, a casting method, and the like. At this time, the thickness of the film to be coated is 150-200 ⁇ m, but is not limited thereto.
- the drying time is 10 to 300 seconds, preferably 5 to 15 seconds, more preferably 10 seconds, and the drying temperature is room temperature, specifically 15 to 30 ° C. Yes, preferably 20-25°C.
- the temperature for immersion in hot water is 70 to 100°C, preferably 70 to 80°C, more preferably 80°C.
- the time for immersion in hot water is 5 to 60 minutes, preferably 10 to 30 minutes, more preferably 10 minutes.
- the temperature when immersed in cold water is preferably 20 to 25°C.
- the time for immersion in cold water is preferably 30 to 90 minutes, more preferably 60 minutes.
- the drying time is 10 seconds at a temperature of 20 to 25 ° C.
- the hot water immersion time is 80 ° C. for 10 minutes
- the cold water immersion time is 20 to 25 ° C. for 60 minutes. is more preferred.
- the cells are intestinal epithelial cells, epithelial cells of other tissues or organs, or cells constituting the epidermis, and the tissue is intestinal epithelial tissue, other epithelial tissue, or epidermal tissue. is not limited to
- the porous cellulose derivative is selected from, but not limited to, cellulose acetate, cellulose nitrate, or regenerated cellulose.
- the material of the polymer microfiber is gelatin, polysaccharide, collagen, polycaprolactone, polylactic acid, polyglycolic acid, poly-p-dioxanone, polyhydroxybutyric acid, trimethylene carbonate, polyacrylic acid derivative or poly methacrylic acid derivatives or copolymers thereof, or water-soluble polymers of polyvinyl alcohol, polyethylene oxide, polyacrylamide, polyvinylpyrrolidone, dextran or polyethylene glycol, or crosslinked materials thereof, or mixtures thereof , but not limited to.
- polysaccharide examples include cellulose, oxidized derivatives of cellulose, chitin, chitosan, agarose, and carrageenan.
- the substrate is preferably a glass substrate, but is not limited to this.
- Tissue Model Another embodiment of the present invention is a tissue model.
- the biological tissue model is produced by using the transparent two-layer substrate and culturing cells and/or tissues on polymer microfibers.
- the culture is preferably air-liquid interface culture, but is not limited to this.
- the cells are intestinal epithelial cells, epithelial cells of other tissues or organs, or cells constituting the epidermis, and the tissue is intestinal epithelial tissue, other epithelial tissue, or epidermal tissue,
- the biological tissue models is selected from an intestinal epithelial tissue model or another epithelial tissue model or an epidermal tissue model.
- the intestinal epithelial cells are preferably Caco-2 cells, but are not limited to this.
- the intestinal epithelial tissue model has properties similar to those of the intestinal epithelial tissue of a living body, specifically, villus structure, microvillus structure, digestive enzyme activity, drug-metabolizing enzyme activity and/or Or a biological tissue model having mucus-producing ability. Therefore, the biological tissue model of the present invention can be used for metabolism and absorption research in place of in vivo animal experiments in drug discovery research and functional food development research, including drug metabolism research. In addition, the tissue of this biological tissue model can be used for application to a living body.
- Another embodiment of the present invention is a method for preparing a biological tissue model.
- a method for producing a biological tissue model by using the transparent two-layer base material and culturing cells and/or tissues on polymer microfibers.
- the culture is preferably air-liquid interface culture, but is not limited to this.
- the cells are intestinal epithelial cells or epithelial cells of other tissues or organs, or cells constituting epidermis, and the tissue is intestinal epithelial tissue, other epithelial tissue, or epidermal tissue.
- the biological tissue model is selected from an intestinal epithelial tissue model, other epithelial tissue models, or an epidermal tissue model.
- the intestinal epithelial tissue model has villus structure, microvillus structure, digestive enzyme activity, drug metabolizing enzyme activity and/or mucus production ability. That is, it is possible to prepare an intestinal epithelial tissue model having properties similar to those of a living intestinal epithelial tissue by the method for preparing a biological tissue model of the present invention.
- the tissue produced by this production method can be applied to tissue transplantation into a living body.
- Example 1 Preparation of a highly transparent porous cellulose acetate film and preparation of a two-layer substrate composed of gelatin fibers
- Preparation of a highly transparent and porous cellulose acetate film and gelatin fibers on the prepared cellulose acetate film A two-layer scaffold for the culture of intestinal epithelial cells spun from
- Reagents 1-1 The following reagents were used to prepare a porous cellulose acetate film.
- Cellulose Acetate FUJIFILM Wako Pure Chemical Industries, Ltd., Osaka
- Acetone FUJIFILM Wako Pure Chemical Co., Ltd., Osaka
- Formamide FUJIFILM Wako Pure Chemical Co., Ltd., Osaka
- Nitta Gelatin beMatrix registered trademark
- Gelatin LS-H Pegskin Alkali-Processed Gelatin
- Nitta Gelatin Osaka
- HFIP 1,1,1,3,3,3-Hexafluoropropan-2-ol
- the cellulose acetate film was cut into 6 ⁇ 6 cm pieces with scissors, immersed in a ⁇ 100 mm dish containing 20 mL of Milli-Q, wrapped with Parafilm, and dried. Incubate overnight. It was taken out the next day and the water absorption was measured with a heating dry moisture meter.
- the surface of the produced cellulose acetate film exposed to air is called the front side
- the surface in contact with the glass plate is called the back side.
- the hot water temperature was 80°C. Based on the hot water treatment time of 10 minutes, 3 samples (No. 4 to 6) of 5 minutes and 30 minutes were prepared. The drying time and thickness were set to 30 sec and 200 ⁇ m as in previous studies.
- a cellulose acetate film was produced with a drying time of 10 seconds.
- cellulose acetate film sample No. 8 which was produced under porous conditions, was white and opaque, and was unsuitable for time-lapse observation because it did not transmit light. Therefore, an experiment was conducted to see if a transparent porous cellulose acetate film could be produced by reducing the thickness from 200 ⁇ m.
- Cellulose acetate film No. 13 which has a thickness of 150 ⁇ m under porous conditions, has a transparent part and a white part, and we observed whether there was a difference between the transparent part and the white part. Visual observation of the cellulose acetate film produced under porous conditions revealed that the front and back surfaces were different.
- a cellulose acetate film with a thickness of 150 ⁇ m to 200 ⁇ m was cut in increments of 10 ⁇ m to produce a cellulose acetate film. did it. Therefore, the currently optimized cellulose acetate film production conditions were [10 sec drying ⁇ 80°C (10 min) treatment, 200 ⁇ m thickness] and it was white and opaque.
- the conditions for becoming porous were [10 sec drying ⁇ 80 °C (10 min) treatment, 200 ⁇ m thickness], and the presence or absence of cold water treatment for solvent removal was investigated.
- Cellulose acetate film made porous [10 sec drying ⁇ 80 °C (10 min) treatment, 200 ⁇ m thickness] and cold water treatment (20-25 °C (60 min)) were added after hot water treatment [ Cellulose acetate films prepared by drying for 10 sec ⁇ 80°C (10 min) ⁇ treatment at 20-25°C (60 min), 200 ⁇ m thick] were observed with a scanning electron microscope (SEM) and compared. A cleaner porous structure was observed with cold water treatment (not shown). Therefore, since a two-layer substrate in which gelatin fibers are spun onto the produced cellulose acetate film is used as a culture substrate, cold water treatment was also performed to remove the solvent from the cellulose acetate film.
- SEM scanning electron microscope
- the cellulose acetate film produced under the conditions for becoming porous is "CA film P" and notation.
- a two-layer base material with gelatin fibers spun on the back side was immersed in liquid nitrogen, and a cross-sectional image of the fracture observed with a scanning electron microscope is shown in Fig. 1. It can be seen that the front side has smaller pore sizes and the back side has larger pore sizes. Therefore, it was considered that the fiber was spun on the front side, which has smaller pores, and the back side, which has larger pores than the front side, was immersed in the liquid phase, thereby stabilizing the supply of the medium.
- CA Film P when CA Film P was immersed in Milli-Q water, it changed from opaque white to transparent milky white. As a result, transparency increased and the amount of transmitted light increased, so it was thought that observation with a phase-contrast microscope was possible. Therefore, it was found that the CA film P was a porous cellulose acetate film with high transparency when wet.
- the rotation speed of the drum collector was 2500 rpm, the distance between the drum collector and the spinneret was 15 cm, the movement speed of the spinneret was 10 mm/sec, the movement width was 100 mm, the applied voltage was 18 kV, and the spinning speed was 1.5 mL/h.
- 3 mL of gelatin solution was spun at a humidity of 30% or higher. After fiber spinning, the completed two-layer substrate was attached to a rectangular and deep empty water bath, and air-dried in a fume hood for about 2 hours to remove residual solvent and dry the gelatin fibers.
- the prepared two-layer base material was formed into an arbitrary size (approximately 1 ⁇ 1 cm) with scissors. Subsequently, the two-layer base material was immersed in two types of sterilized water and culture solution, and the solution was changed once every two days in an incubator (37°C, 5% CO 2 ) until 7 days later (Day7). It was stored until 21 days later (Day 14) and 21 days later (Day 21). In order to observe the preserved samples with a scanning electron microscope, dehydration was performed in order with 20%, 50%, 75%, and 100% ethanol in order to remove moisture from the culture medium contained in the samples. Freeze-drying treatment using butyl alcohol (freezing in liquid nitrogen and drying under vacuum for 6 hours) was performed to completely dry.
- FIG. 2 shows an image of the fiber-spun two-layer substrate observed with a scanning electron microscope. It was found that both the fiber layer and the CA film P are suitable as culture substrates because they have good liquid permeability.
- Fig. 3 shows an image of the fabricated two-layer base material observed with a scanning microscope. Since the fiber diameter hardly changed even if the number of days of immersion increased, it is considered that the fiber can be used for long-term cell culture.
- Example 2 Preparation of an intestinal epithelial tissue model using a two-layer base material of cellulose acetate film and gelatin Cells were subjected to stationary culture in liquid (hereinafter referred to as "liquid culture”) or gas phase-liquid interface culture (hereinafter referred to as "air-liquid culture”), and Caco- 2 We examined whether the morphological changes of cells can be observed over time. The experimental method and results are described below.
- liquid culture liquid
- air-liquid culture gas phase-liquid interface culture
- Nitta Gelatin beMatrix registered trademark
- Gelatin LS-H (Pigskin Alkali-Processed Gelatin): Nitta Gelatin Co., Ltd., Osaka
- 1,1,1,3,3,3-Hexafluoropropan-2-ol Cat# PC4750, Apollo Scientific, UK
- 25% glutaraldehyde solution Cat# 073-00536, Fujifilm Wako Pure Chemical Industries, Ltd., Osaka
- Matsunami glass bottom dish (dish diameter: ⁇ 35 mm, glass diameter: ⁇ 27 mm, glass thickness: No.1S (0.16-0.19 mm)): Cat# D11040H, Matsunami Glass Industry Co., Ltd., Osaka (2) Alexa FluorTM 568 phalloidin: Cat# A12380, Thermo Fisher Scientific, Massachusetts, USA (3) Hoechst 33342: Thermo Fisher Scientific, Massachusetts, USA (4) 4% paraformaldehyde/phosphate buffer: Cat# 163-20145, Fujifilm Wako Pure Chemical Industries, Ltd., Osaka (5) TRITON® X-100: Cat# 648466, Wako Pure Chemical Industries, Ltd., Osaka (6) Albumin, bovine serum, prosthesis-free: Cat# 018-15154, Fujifilm Wako Pure Chemical Industries, Ltd., Osaka
- the cell culture field was 2 ⁇ 2 cm or 4 cm 2 inside the silicon square to wrap the bilayer substrate around the silicon square so that the Caco-2 cells and culture would not leak out.
- 500 ⁇ L of cell suspension was seeded within the 4 cm 2 . It was stored overnight in an incubator (37° C., 5% CO 2 ) until Caco-2 adhered to the bilayer substrate.
- 200 ⁇ L of the culture medium was added to the inside of the silicon square and stored overnight in an incubator (37° C., 5% CO 2 ).
- the square silicon was removed, and 20 mL of culture medium was added to immerse the two-layer substrate in the culture medium. Thereafter, the cells were observed under a phase-contrast microscope and the medium was exchanged every 2 to 3 days, and the cells were cultured for 21 days (until Day 21).
- the dyed sample can be observed as it is because it is a two-layer substrate with a CA film P that is highly transparent when wet.
- the cell-adhesion surface side is turned over to make it observable by contacting the bottom surface of the dish, and fluorescence observation is performed using a confocal microscope. Observations were made inside out for comparison. Observation conditions (gain, offset, etc.) were not constant among the samples, but were adjusted so that the morphology could be clearly observed.
- TCPS tissue-culture-treatedpolystyrene 35mm dish
- cell adhesion could be confirmed, and it was possible to observe the growth status over time.
- the overall structure was planar, and no three-dimensional structure specific to intestinal epithelial cells was observed.
- the cell seeding method the cells and the culture medium flowed out of the fiber in the drop seeding method, and the number of adhered cells was smaller than when the silicon ring was used. I decided to do
- the prepared two-layer substrate was cut into 2.5 ⁇ 2.5 cm with scissors.
- the bilayer substrate was pre-incubated overnight or longer.
- the culture volume was 1.6 mL per 1 cm 2 of the two-layer substrate.
- 500 ⁇ L of a cell suspension was prepared by preparing Caco-2 (passage number 58) in logarithmic growth phase at a seeding density of 5.53 ⁇ 10 4 cells/cm 2 .
- the cell culture field was 2 x 2 cm or 4 cm 2 inside the silicon square to wrap the bilayer substrate around the silicon square so that the Caco-2 cells and culture did not leak out.
- 500 ⁇ L of cell suspension was seeded within the 4 cm 2 .
- a two-layer base material of a cellulose acetate film seeded with cells was placed on the square silicon, and the square silicon was held down from above. After that, observation with a phase-contrast microscope and medium exchange were carried out every 2 to 3 days, and culture was carried out for 21 days (until Day 21).
- the cells were fixed with 4% paraformaldehyde (room temperature, 15 min) and stored in a -4°C refrigerator until staining.
- cell membrane permeabilization was performed using 0.15% Triton X-100 (diluted in 1 ⁇ PBS), followed by blocking with 5% BSA (diluted in 1 ⁇ PBS) (room temperature, 30 min).
- Alexa Fluor 568 Phalloidin (1:400, 1% BSA dilution) was reacted at room temperature for 30 min, and Hoechst 33342 (1:1000, 1 ⁇ PBS dilution) was reacted at room temperature for 15 min to obtain F- Actin and nuclei were stained.
- the dyed sample can be observed as it is because it is a two-layer substrate having CA film P with high transparency.
- the two-layer base material with paper which is a comparative example, was turned over so that the cell-adhesion side was in contact with the bottom surface of the dish to make it observable, and fluorescence observation was performed using a confocal microscope. In order to compare, it was similarly turned inside out and observed. Observation conditions (gain, offset, etc.) were not constant among the samples, but were adjusted so that the morphology could be clearly observed.
- Fig. 7 shows a phase-contrast image with a 10x objective lens, which clearly shows the swelling of the cells.
- the structure in the phase-contrast image confirmed in FIG. 7 is considered to be the three-dimensional structure of the villus process, and observation over time with a phase-contrast microscope is possible.
- FIG. 9 shows images of the characteristic morphology of intestinal epithelial cells observed with a phase-contrast microscope and a confocal microscope (CLSM). Since the gelatin fibers emit red autofluorescence, we found that nuclei and actin existed on the gelatin fibers on Day 7. Around Day 10, cavities began to form between the gelatin fibers and the nuclei, and on Day 12, the monolayer nuclei were elevated and the hemispheres were hollow, a three-dimensional structure specific to intestinal epithelial cells. The specific three-dimensional structure of Day12 matured until Day21.
- Example 3 Observation of the structure of the intestinal epithelial tissue model by scanning microscope (SEM) The structure of the intestinal epithelial tissue model prepared in Example 2 was observed by a scanning microscope (SEM), and the cell used conventionally was used. It was compared with the intestinal epithelial tissue obtained by culturing on the culture insert.
- each sample Fix with 4% paraformaldehyde/phosphate buffer (Cat#163-20145, FUJIFILM Wako Pure Chemical Industries, Ltd., Osaka), replace with alcohol according to the usual method, dehydrate, air dry (at least 1 day), and then Au. Sputtering was performed, and the structural change of each sample was observed with a scanning electron microscope.
- paraformaldehyde/phosphate buffer Cat#163-20145, FUJIFILM Wako Pure Chemical Industries, Ltd., Osaka
- FIG. 10A shows an SEM observation image of a sample obtained by air-liquid culture of a two-layer substrate consisting of a CA film P layer and a gelatin fiber layer. It was observed that three-dimensional structures resembling villous processes were formed with the passage of culture days. Microvillus-like structures were also observed at high magnification.
- Fig. 10B shows an SEM observation image of a sample obtained by submerged culture of a two-layer substrate consisting of a CA film P layer and a gelatin fiber layer.
- the formation of three-dimensional structures such as villus projections was not observed in any number of culture days, but microvilli-like structures were observed at high magnification.
- Fig. 10C shows the SEM observation image of the sample obtained by air-liquid culture using the cell culture insert. While Day5 was flat, a rise was observed from Day7. However, it was a nearly planar structure like a scab, which is difficult to call a finger-like villus process. It was thought that there was a possibility that it was a mucus layer rather than a structure.
- Fig. 10D shows the SEM observation image of the sample obtained by submerged culture using the cell culture insert.
- the formation of three-dimensional structures such as villus projections was not observed at any number of culture days, but microvilli-like structures were observed at high magnification.
- Example 4 Observation of alanine aminopeptidase (ANPEP) activity in an intestinal epithelial tissue model Digestive enzymes are produced in the intestinal epithelial tissue of a living body. Therefore, for the purpose of confirming the enzymatic activity, which is the function of the intestinal epithelial tissue model prepared in Example 2, the time course of the digestive enzyme alanine aminopeptidase (ANPEP) activity was observed.
- ANPEP alanine aminopeptidase
- Caco-2 cells were seeded in the medium to be 70% confluent.
- ANPEP alanine aminopeptidase
- ANPEP activity was measured by measuring the absorbance of p-nitroaniline produced by hydrolysis of L-alanine 4-nitroanilide according to the method of Shim et al. (Shim K.-Y., et al, Biomed Microdevices 2017; 19:37).
- Example 5 Observation of CYP3A4 activity in intestinal epithelial tissue model In vivo intestinal epithelial tissue has CYP3A4 activity. Therefore, for the purpose of confirming the enzymatic activity, which is the function of the intestinal epithelial tissue model prepared in Example 2, the time course of CYP3A4 activity, which is a drug-metabolizing enzyme, was observed.
- Caco-2 cells were seeded in the medium to be 70% confluent.
- CYP3A4 activity was measured after 5 days of culture (Day 5) (2 days after transfer to each culture condition), 7 days (Day 7), 10 days (Day 10), 12 days (Day 12), and 21 days (Day 21). did.
- CYP3A4 activity was measured according to the method of Shim et al., using Luciferin-IPA as a substrate and treating D-Luciferin produced with a solution for detecting luciferin luminescence containing luciferase, and measuring luminescence (Shim K.- Y., et al, Biomed Microdevices 2017;19:37.).
- the intestinal epithelial tissue model prepared using a two-layer substrate consisting of a CA film P layer and a gelatin fiber layer was found to have CYP3A4 activity in the same way as the intestinal epithelial tissue in vivo.
- Example 6 Observation of mucus production in an intestinal epithelial tissue model In vivo intestinal epithelial tissue, mucus is produced. Therefore, we investigated the mucus-producing ability of an intestinal epithelial tissue model prepared using a two-layer substrate consisting of a CA film P layer and a gelatin fiber layer.
- the light intensity and white balance were kept constant, images were acquired from 10 fields of view/sample at 20x magnification, and image analysis was performed using the following method.
- the CA film was peeled off and only the cell and fiber layers were observed.
- Image analysis was performed by the following method.
- (ii) Using the H image, only blue portions (threshold: 0.5 to 0.6), which are portions stained with alcian blue ( mucus), were specified and extracted.
- (Image of H') (iii)
- the image of H′ processed in (ii) was superimposed on the image of V, the brightness of only the blue portion was extracted, and the luminance value was inverted so that the darker the image, the higher the luminance value.
- the amount of mucus produced was expressed as a percentage.
- FIG. 13A shows representative examples of phase-contrast microscope images of each sample at each time point.
- FIG. 13B shows the change over time in the mucus-producing capacity of each experimental group, which was obtained in terms of the mucus-producing amount.
- the intestinal epithelial tissue model prepared using the two-layer base material of the CA film P layer and the gelatin fiber layer has the same mucus-producing ability as the intestinal epithelial tissue in vivo. rice field.
- Example 7 Evaluation of barrier function in an intestinal epithelial tissue model In vivo intestinal epithelial tissue, a barrier function was observed in which tight junctions restrict the permeation of substances containing ions between the apical side and the basal side of cells. be done.
- the transepithelial electrical resistance (TEER) value is measured as a method of evaluating the barrier function in epithelial tissue. Therefore, the barrier function was evaluated by measuring the TEER value of the intestinal epithelial tissue model prepared from the transparent two-layer base material of the present invention.
- Caco-2 cells were seeded in the medium to be 70% confluent.
- TEER values were measured at two time points, 12 days after culture (Day 12) (10 days after transfer to each culture condition) and 21 days (Day 21) (19 days after transfer to each culture condition).
- the transparent two-layer substrate of the present invention cannot be attached to a commercially available TEER device as it is, a chamber for measurement originally made with a 3D printer shown in FIG. ). Since this chamber also has a space for attaching commercially available electrodes for measuring TEER values, a test electrode (MERSSTX04) and an adjustable electrode (MERSSTX03) were attached to Millipore's Millicell (registered trademark) ERS-2 Epithelial Volt-0 hm Meter. ) was attached and measured. At the time of the measurement, the space between the upper and lower chambers of the two-layer substrate was filled with the culture medium and the measurement was performed.
- TEER value (R all -R blank ) x S
- R all Resistance measurement value using a sample in which cells are cultured on the two-layer substrate
- R blank Resistance measurement value using only the two-layer substrate without cell culture
- S Effective culture area.
- Cell culture insert was 1.12 cm 2 , bilayer substrate 1 cm 2 .
- the intestinal epithelial tissue model produced by the air-liquid interface culture of the transparent two-layer substrate has a significantly higher TEER value than the tissue model produced by other culture methods after 12 days of culture (Day 12) and 21 days after culture (Day 21). Indicated.
- the TEER value of an intestinal epithelial tissue model, in which Caco-2 is cultured in a cell culture insert and used for a substance permeability assay is reported to be approximately 110 to 850 ohms square centimeter in the literature (L. -F. Blume, et al., Pharmazie 65 (2010) 1, 19-24). Even when compared with these values, the intestinal epithelial tissue model prepared by air-liquid interface culture using the two-layer substrate showed a significantly high TEER value.
- the intestinal epithelial tissue model created using a two-layer base material consisting of a CA film P layer and a gelatin fiber layer has a high barrier function, similar to the intestinal epithelial tissue in vivo.
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Sustainable Development (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
(1) セルロース誘導体を有機溶媒に溶解し、セルロース誘導体の有機溶媒溶液を調製するステップ、
(2) 前記セルロース誘導体の有機溶媒溶液を基板上にコーティングし、乾燥することによってセルロース誘導体膜を調製するステップ、
(3) 前記セルロース誘導体膜を所定の時間乾燥し、次に熱水に所定の時間浸漬し、次に冷水に所定の時間浸漬し、次に基板より剥離することにより、多孔性セルロース誘導体膜を調製するステップ、及び、
(4) エレクトロスピニング法によって、前記多孔性セルロース誘導体膜上に高分子マイクロファイバーを紡糸して積層するステップ、
を含む、細胞及び/又は組織の培養用の透明二層基材の製造方法を提供する。
本発明の実施形態の1つは、湿潤条件下光透過性を有する多孔性セルロース誘導体膜に高分子マイクロファイバーが紡糸され積層された、細胞及び/又は組織の培養用の透明二層基材である。
本発明のもう1つの実施形態は、透明二層基材の製造方法である。本製造方法は、多孔性セルロース誘導体膜を製造するステップ、及び、該多孔性セルロース誘導体膜上にエレクトロスピニング法によって高分子マイクロファイバ―を紡糸し、積層するステップを含む。
(1) セルロース誘導体を有機溶媒に溶解し、セルロース誘導体の有機溶媒溶液を調製するステップ、
(2) 前記セルロース誘導体の有機溶媒溶液を基板上にコーティングし、乾燥することによってセルロース誘導体膜を調製するステップ、
(3) 前記セルロース誘導体膜を所定の時間乾燥し、次に熱水に所定の時間浸漬し、次に冷水に所定の時間浸漬し、次に基板より剥離することにより、多孔性セルロース誘導体膜を調製するステップ、及び、
(4) エレクトロスピニング法によって、前記多孔性セルロース誘導体膜上に高分子マイクロファイバーを紡糸するステップ、
を含む、細胞及び/又は組織の培養用の透明二層基材の製造方法である。
本発明の実施形態のもう1つの実施形態は、生体組織モデルである。前記生体組織モデルは、前記透明二層基材を用い、高分子マイクロファイバー上で細胞及び/又は組織を培養することによって作製される。
本発明のもう1つの実施形態は、生体組織モデルの作製方法である。前記透明二層基材を用い、高分子マイクロファイバー上で細胞及び/又は組織を培養する生体組織モデルの作製方法である。
透明度が高く多孔質な酢酸セルロースフィルムの作製と、作製した酢酸セルロースフィルム上にゼラチンファイバーを紡糸した腸管上皮細胞の培養足場となる二層基材の製造を行った。
1-1. 多孔質化した酢酸セルロースフィルムの作製には以下の試薬を使用した。
(1) 酢酸セルロース:富士フイルム和光純薬株式会社、大阪
(2) アセトン:富士フイルム和光純薬株式会社、大阪
(3) ホルムアミド:富士フイルム和光純薬株式会社、大阪
(1) 新田ゼラチン beMatrix(登録商標)ゼラチンLS-H(豚皮アルカリ処理ゼラチン)、新田ゼラチン、大阪
(2) 1,1,1,3,3,3-Hexafluoropropan-2-ol(HFIP):Cat#PC4750、Apollo Scientific、イギリス
(3) 25%グルタルアルデヒド溶液:Cat#073-00536、富士フイルム和光純薬株式会社、大阪
1-2-1. 多孔質化した酢酸セルロースフィルムの作製には以下の機器を使用した。
(1) ガラス板(15 cm×20 cm×5 mm):株式会社三商
(2) 膜厚調整機能付きフィルムアプリケーター 150mm:Allgood
(3) 恒温槽、Cat#FTB-01:東京硝子器械工業株式会社
(4) 加熱乾燥水分計:Cat#MOC63u、株式会社島津製作所
(1) エレクトロスピニング装置:Cat# NANON-03、株式会社メック、福岡
(2) チューブレススピナレット#75:Cat# S-TU/75、株式会社メック、福岡
(3) ドラムコレクター#φ200W200 (直径200 mm、幅200 mm):Cat# C-DR/D200W200、株式会社メック、福岡
(4) テルモシリンジ(登録商標) 1ml ツベルクリン用 電子線滅菌:Cat# SS-01T、テルモ株式会社、東京
(5) テルモ注射針(電子線滅菌済、22G×1 1/4):テルモ株式会社、東京
(6) 3M(商標) マスキングテープ 243J Plus:スリーエム ジャパン株式会社、東京
(7) マグネトロンスパッタ装置:Cat# MSP-10、株式会社真空デバイス、茨城
(8) 走査型電子顕微鏡:Cat# VE-9800、株式会社キーエンス、大阪
酢酸セルロースフィルムも吸水性が良くないと培地を保持する液相の基材に使用できない。しかし、既往研究であるロブ-スリラーヤン法(大矢晴彦, Sourirajanと非対称膜の発明まで, MRCニュース, No. 30, 2003)の酢酸セルロースフィルムの作製方法では、多孔質の酢酸セルロースフィルムが作製できなかった。そこで、酢酸セルロースフィルムの多孔質化を行った。
スクリュー管瓶に酢酸セルロースとホルムアミドとアセトンの重量比[g]が3:5:10になるよう調製した。スクリュー管瓶に入った酢酸セルロース溶液を室温下で一晩撹拌した。翌日、酢酸セルロース溶液をガラス板の上に細長くキャストした。すぐに膜厚調整機能付きフィルムアプリケーターで酢酸セルロースフィルム溶液を伸ばしフィルムを形成した。ガラス板上で乾燥させ、その後高温のミリQが入った恒温槽に浸漬させた。そして、ガラス板ごと取り出し、室温のミリQが入った水槽に浸漬させた後、ガラス板を取り出し、ガラス板からピンセットで酢酸セルロースフィルムを取り外し、ペーパータオルで酢酸セルロースフィルムの水分を拭き取った。多孔質で透明度の高い酢酸セルロースフィルム作製のために、厚み・乾燥時間・熱水処理・冷水処理の4項目において条件検討を行った。一晩以上自然乾燥させた酢酸セルロースフィルムを液体窒素に浸漬させた状態でピンセットで割り、真空下でAuスパッタリング(ターゲット:Au、放電時の電流:35 mA、スパッタリング時間:0.5 min)を行い、走査型電子顕微鏡で観察した。
作製条件の各項目(フィルムの厚み、乾燥時間、熱水処理及び冷水処理)において作製した酢酸セルロース(CA)フィルムを走査型顕微鏡で観察することにより条件検討を行った。
上記「1-3. 多孔質化した透明度の高い酢酸セルロースフィルムの作製」で作製した吸水性が良く濡れると透明度が上がる多孔質化した酢酸セルロースフィルム層と、その上に細胞を接着させる層(=ゼラチンファイバー)を有する経時観察可能な二層基材を作製した。以下に、実験方法と結果とを記載する。
サンプル管に終濃度が10 w/v%となるように粉末ゼラチンとヘキサフルオロ-2-プロパノール(HFIP)とのゼラチン溶液を調製し、室温下で一晩攪拌した。翌日、シリンジにゼラチン溶液を加え、エレクトロスピニング装置(NANON)に設置した。ファイバーの紡糸先は、ドラムコレクターに多孔質化した酢酸セルロースフィルムを貼り付けたものとした。ドラムコレクターの回転数を2500 rpm、ドラムコレクターと紡糸口の距離を15 cm、紡糸口の移動速度を10 mm/sec、移動幅を100 mm、印加電圧を18 kV、紡糸速度を1.5 mL/h、湿度を30%以上として、ゼラチン溶液3 mLを紡糸した。ファイバー紡糸後、長方形で深さのある空の水槽に、完成した二層基材を貼り、ドラフト内で約2時間風乾させ残存した溶媒を除去し、ゼラチンファイバーの乾燥を行なった。続いて、二層基材を貼った水槽に、25%グルタルアルデヒド溶液を適量加えたディッシュを入れて密閉し、室温下で一晩蒸気架橋した。蒸気架橋後、ドラフト内で約2時間風乾させ残存したグルタルアルデヒドを除去した。このようにグルタルアルデヒドによる架橋によって、ゼラチンの不溶化を行った。
ファイバーを紡糸した二層基材を走査型電子顕微鏡で観察した像を図2に示す。ファイバー層もCAフィルムPも通液性が良いので培養基材に適しているということがわかった。
ロブ-スリラーヤン法を改変して多孔性酢酸セルロースフィルムの作製条件を確立した。湿潤時は透明度が高く、多孔質化した酢酸セルロースフィルムが作製でき、その上にエレクトロスピニング法を用いて、ゼラチンファイバーを紡糸することで二層基材を作製した。作製した二層基材は、細胞培養環境下(培養液中に浸漬、37℃、5%CO2)においてファイバー径と形態が比較的安定であり、ファイバー層が酢酸セルロースフィルムから剥離しなかったため、細胞培養実験に使用可能であることが示された。
実施例1で作製した湿潤時に透明度が高く吸水性の良い二層基材を用いてCaco-2細胞を液内静置培養「以下、「液内培養」と記載」又は、気相-液相界面培養(以下、「気液培養」と記載)を行い、培養21日後(Day21)までCaco-2細胞の形態変化が経時観察ができるかを検討した。その実験方法と結果とを以下に記載した。
2-1. 試薬
2-1-1. 二層基材の作製に使用した試薬を以下に記載した。
(1) 新田ゼラチン beMatrix(登録商標)ゼラチンLS-H、(豚皮アルカリ処理ゼラチン):新田ゼラチン株式会社、大阪
(2) 1,1,1,3,3,3-Hexafluoropropan-2-ol:Cat# PC4750、Apollo Scientific、イギリス
(3) 25%グルタルアルデヒド溶液:Cat# 073-00536、富士フイルム和光純薬株式会社、大阪
(1) ヒト大腸癌由来細胞Caco-2(ECACC由来):Cat# RCB0988、理研BRC細胞バンク
(2) FALCON(登録商標) ペトリディッシュ:Cat# 351029、コーニング、アメリカ
(3) ダルベッコ変法イーグル培地(4.5 g/l グルコース)(L-グルタミン含有、ピルビン酸不含)(液体):Cat# 08459-35、ナカライテスク株式会社、京都
(4) ペニシリン/ストレプトマイシン:Cat# 15140-122、サーモフィッシャーサイエンティフィック、マサチューセッツ、アメリカ
(5) 0.5w/v% トリプシン-5.3mmol/l EDTA-4Na 溶液(フェノールレッド不含)(×10):Cat# 208-17251、富士フイルム和光純薬株式会社、大阪
(6) ダルベッコリン酸緩衝生理食塩水(10倍濃縮):Cat# 11482-15、ナカライテスク株式会社、京都
(7) Fetal Bovine Serum (Dominican Republic Origin):Cat# FB-1061/500、Lot# 12868、Biosera
(8) MEM非必須アミノ酸溶液:Cat# 06344-14、ナカライテスク株式会社、京都
(1) 松波ガラスボトムディッシュ(dish径:φ35 mm、ガラス径:φ27 mm、ガラス厚み:No.1S (0.16-0.19 mm)):Cat# D11040H、松波硝子工業株式会社、大阪
(2) Alexa Fluor(商標) 568 phalloidin:Cat# A12380、サーモフィッシャーサイエンティフィック、マサチューセッツ、アメリカ
(3) Hoechst 33342:サーモフィッシャーサイエンティフィック、マサチューセッツ、アメリカ
(4) 4%パラホルムアルデヒド・リン酸緩衝液:Cat# 163-20145、富士フイルム和光純薬株式会社、大阪
(5) TRITON(登録商標) X-100:Cat# 648466、和光純薬工業株式会社、大阪
(6) アルブミン、ウシ血清由来、プロテーゼ不含:Cat# 018-15154、富士フイルム和光純薬株式会社、大阪
(1) 無水エタノール:Cat# 321-00025、富士フイルム和光純薬株式会社、大阪
(2) t-ブチルアルコール:Cat# 025-03396、富士フイルム和光純薬株式会社、大阪
2-2-1. 二層基材の作製には以下の機器を使用した。
(1) エレクトロスピニング装置:Cat# NANON-03、株式会社メック、福岡
(2) チューブレススピナレット#75:Cat# S-TU/75、株式会社メック、福岡
(3) ドラムコレクター#φ200W200 (直径200 mm、幅200 mm):Cat# C-DR/D200W200、株式会社メック、福岡
(4) テルモシリンジ(登録商標) 1ml ツベルクリン用 電子線滅菌:Cat# SS-01T、テルモ株式会社、東京
(5) テルモ注射針(電子線滅菌済、22G×1 1/4):テルモ株式会社、東京
(6) クレシアEF ハンドタオル ソフトタイプ 100:日本製紙クレシア株式会社、東京
(7) 3M(商標) マスキングテープ 243J Plus:スリーエム ジャパン株式会社、東京
(8) Electric Drying Oven:Cat# DRA330DA、株式会社アドバンテック、東京
(9) マグネトロンスパッタ装置:Cat# MSP-10、株式会社真空デバイス、茨城
(10) 走査型電子顕微鏡:Cat# VE-9800、株式会社キーエンス、大阪
(1) バイオハザード対策用キャビネット クラス II タイプA:Cat# MHE-131AJ、三洋電機株式会社、大阪
(2) テーブルトップ型バイオクリーンベンチ(KVM型):Cat# KUM-756、日本エアーテック株式会社、東京
(3) Digital microscope:Cat# MS-200、オリンパス株式会社、東京
(4) 位相差顕微鏡:Cat# Eclipse TS100、株式会社ニコン、東京
(5) 倒立型リサーチ顕微鏡:Cat# IX81、オリンパス株式会社、東京
(6) 共焦点レーザー顕微鏡:Cat# FLUOVIEW FV1000、オリンパス株式会社、東京
多孔質化した酢酸セルロースフィルム層とゼラチンファイバー層から成る二層基材においてCaco-2細胞が接着と生育が可能かどうかを調べるために液内静置培養を行った。以下に詳細に記載する。
実施例1に示した方法で二層基材を作製した。作製した二層基材をハサミで2.5×2.5 cmに切断した。この二層基材の未反応のグルタルアルデヒドを除去するため、培養液内に浸漬させ、インキュベーター内(37℃、5%CO2)で保存した(以下、この工程を「プレインキュベーション」と呼称する)。培養液量は二層基材1 cm2にあたり1.6 mLとした。その後、対数増殖期にあるCaco-2(継代数58)を播種濃度が5.53×104 cells/cm2となるように調製した細胞懸濁液500 μLを用意した。Caco-2細胞と培養が漏れ出ないように四角シリコンで二層基材の周りを覆うため、細胞培養場は、四角シリコンの内側2×2 cmつまり4 cm2とした。その4 cm2内に細胞懸濁液500 μLを播種した。Caco-2が二層基材に接着するまで、一晩インキュベーター内(37℃、5%CO2)で保存した。翌日、四角シリコンの内側に培養液を200 μL添加し、一晩インキュベーター内(37℃、5%CO2)で保存した。翌日四角シリコンを取り外し、培養液を20 mL添加して二層基材を培養液内に浸漬させた。その後位相差顕微鏡での観察と培地交換を2~3日毎に行い、21日間(Day21まで)培養を行なった。
実施例1のようにCAフィルムP上にゼラチンファイバーを3 mL紡糸して作製した二層基材を用いてCaco-2細胞を播種し、21日間(Day21まで)液内静置培養し位相差顕微鏡で観察したDay1、Day 3、Day 5、Day 7、Day 10、Day 13及びDay 21の結果を図4に示した。
次に、気液界面培養を行うことで、絨毛突起特有の三次元構造が作製されて、かつ位相差顕微鏡で経時観察可能であるかを調べた。
上記2-3項と同様の方法で二層基材を作製した。ゼラチンファイバー量と二層基材との光の透過度についての関連性を調べるためにゼラチンファイバー量は1.5、2.0、2.5、3.0 mLとした。また従来技術(非特許文献3)である紙とゼラチンファイバー3.0 mLによる二層基材も作製した。
CAフィルムPの二層基材を用いて気液界面培養を21日間(Day21まで)行い、位相差顕微鏡で経時観察を行なった結果を図6に示した。
以上、実施例1で作製した透明度が高く吸水性の良いCAフィルムPの二層基材を用いて実際にCaco-2細胞を液内静置培養で培養できるかまたは、気相-液相界面培養を行い、培養21日間(Day21まで)においてCaco-2細胞の形態変化が経時観察ができるかを検討した。その結果、CAフィルムPの二層基材における液内静置培養では、Caco-2細胞は培養でき、細胞の形態についても、平面の二次元構造しかできなかったが、経時観察することが可能であった。また、気液界面培養では、紙の二層基材の時と同様な半球状の三次元構造ができ、またその三次元構造の位相差顕微鏡での経時観察も可能であった。これらの結果から、従来の腸管上皮モデルの問題点であった二次元構造という点を改善でき、かつ紙による二層基材での腸管上皮モデル作製の問題点であった光学顕微鏡における経時観察ができないという点も改善できた。すなわち、光学顕微鏡で連続的に経時観察が可能なin vitroの腸管上皮組織モデルの作製に成功した。
実施例2で作製した腸管上皮組織モデルの構造を、走査型顕微鏡(SEM)で構造を観察し、従来から用いられるセルカルチャーインサートで培養して得られる腸管上皮組織と比較した。
Caco-2細胞を70%コンフルエントとなるように培地に播種した。CAフィルムP層とゼラチンファイバー層との二層基材の気液培養又は液内培養、及び、セルカルチャーインサート(Cat#3460、コーニング、米国)の気液培養又は液内培養の4条件で細胞培養した。なお、培養3日後で気液培養又は液内培養に移行させ、1~2日置きに培地交換を行った。
培養5日後(Day5)(各培養条件に移行して2日後)、7日後(Day7)、10日後(Day10)、12日後(Day12)、及び21日後(Day21)の5時点において、各試料を4%パラホルムアルデヒド・リン酸緩衝液(Cat#163-20145、富士フイルム和光純薬株式会社、大阪)で固定し、常法に従いアルコール置換後、脱水し、自然乾燥(1日以上)後、Auスパッタリングを行い、走査型電子顕微鏡で、各試料の構造変化を観察した。
CAフィルムP層とゼラチンファイバー層との二層基材の気液培養で得られた試料のSEM観察像を図10Aに示した。培養日数を経るごとに絨毛突起に似た三次元構造が形成される様子が観察された。高倍率において微絨毛のような構造も観察された。
生体の腸管上皮組織では、消化酵素が産生される。そこで、実施例2で作製した腸管上皮組織モデルの機能である酵素活性を確かめる目的で、消化酵素であるアラニンアミノペプチダーゼ(ANPEP)活性の経時推移を観察した。
Caco-2細胞を70%コンフルエントとなるように培地に播種した。CAフィルムP層とゼラチンファイバー層との二層基材の気液培養又は液内培養、及び、セルカルチャーインサートの気液培養又は液内培養の4条件で細胞培養した。なお、培養3日後で気液培養又は液内培養に移行させ、1~2日置きに培地交換を行った(各N=1)。
培養5日後(Day5)(各培養条件に移行して2日後)、7日後(Day7)、10日後(Day10)、12日後(Day12)、及び21日後(Day21)の5時点でアラニンアミノペプチダーゼ(ANPEP)活性を測定した。ANPEP活性の測定は、Shimらの方法に従い、L-アラニン 4-ニトロアニリドの加水分解により生成するp-ニトロアニリンの吸光度測定により行った(Shim K.-Y., et al, Biomed Microdevices 2017;19:37)。
実験結果を図11に示した。CAフィルムP層とゼラチンファイバー層との二層基材の気液培養又は液内培養、及び、セルカルチャーインサートの気液培養又は液内培養の4条件のいずれにおいても、培養12日後(Day12)まで、ANPEP活性は上昇した。培養21日後(Day21)では、CAフィルムP層とゼラチンファイバー層との二層基材-気液培養ではさらに活性が上昇したが、CAフィルムP層とゼラチンファイバー層との二層基材-液内培養、セルカルチャーインサート-気液培養及びセルカルチャーインサート-液内培養では培養12日後(Day12)と同程度であった。培養法間では気液培養の方が液内培養より活性が高いことが観察された。
生体の腸管上皮組織は、CYP3A4活性を有する。そこで、実施例2で作製した腸管上皮組織モデルの機能である酵素活性を確かめる目的で、薬物代謝酵素であるCYP3A4活性の経時推移を観察した。
Caco-2細胞を70%コンフルエントとなるように培地に播種した。CAフィルムP層とゼラチンファイバー層との二層基材の気液培養又は液内培養、及び、セルカルチャーインサートの気液培養又は液内培養の4条件で細胞培養した。なお、培養3日後で気液培養又は液内培養に移行させ、1~2日置きに培地交換を行った(各N=1)。
培養5日後(Day5)(各培養条件に移行して2日後)、7日後(Day7)、10日後(Day10)、12日後(Day12)、及び21日後(Day21)の5時点でCYP3A4活性を測定した。CYP3A4活性の測定は、Shimらの方法に従い、Luciferin-IPAを基質に用いて、生成するD-Luciferinをルシフェラーゼを含むLuciferin発光検出用溶液で処理した際の発光測定により行った(Shim K.-Y., et al, Biomed Microdevices 2017;19:37.)。
実験結果を図12に示した。培養21日後(Day21)において、CYP3A4活性は、CAフィルムP層とゼラチンファイバー層との二層基材-液内培養、セルカルチャーインサート-液内培養、CAフィルムP層とゼラチンファイバー層との二層基材-気液培養、セルカルチャーインサート-気液培養の順で高く、セルカルチャーインサート-気液培養ではCYP3A4活性の上昇を認めなかった。すなわち、培養法間では液内培養の方が気液培養より活性が高いことが観察された。
生体の腸管上皮組織では、粘液が産生される。そこで、CAフィルムP層とゼラチンファイバー層との二層基材を用いて作製される腸管上皮組織モデルでの粘液産生能を検討した。
Caco-2細胞を70%コンフルエントとなるように培地に播種した。CAフィルムP層とゼラチンファイバー層との二層基材の気液培養又は液内培養、及び、セルカルチャーインサートの気液培養又は液内培養の4条件で細胞培養した。なお、培養3日後で気液培養又は液内培養に移行させ、1~2日置きに培地交換を行った(各N=3)。
(i) Image Jを用いて元画像をHSV(H:Hue色相=色の種類、S:Saturation彩度=色の鮮やかさ、V:Value明度=色の明るさ)に変換した。
(ii) Hの画像を用いてアルシアンブルーで染色された部分(=粘液)である青色の部分のみ(Threshold:0.5~0.6)を指定して抽出した。(H'の画像)
(iii) Vの画像に(ii)の処理をしたH'の画像を重ね合わせ、青色部分のみの明るさを抽出し、暗いほど輝度値が高くなるように反転させた。
(iv) (iii)の処理をしたV+H'画像でヒストグラムから各輝度値当たりのpixel数を求めた。(8-bit画像なので輝度は0~255の256段階で示された。このとき、輝度値が高い方が青色が強い)
(v) 1培養条件について3サンプルあり, 1サンプル10視野撮影しているため、1培養条件について30枚の画像処理を行った。
(vi) 各輝度値とその輝度値を示したpixel数を求めた後、それぞれの値において乗算して総和した値をその培養条件における粘液産生量とした。
図13Aに各試料の各時点での位相差顕微鏡像の代表例を示した。また、図13Bに粘液産生量に換算して得られた各実験群の粘液産生能の経時推移を示した。
生体の腸管上皮組織では、密着結合によって細胞の頂端側と基底側との間でイオンを含む物質の透過が制限されるというバリア機能がみられる。また、上皮組織におけるバリア機能の評価方法として経上皮電気抵抗(TEER)値の測定が行われる。そこで、本発明の透明二層基材で作製した腸管上皮組織モデルについて、TEER値を測定してバリア機能を評価した。
Caco-2細胞を70%コンフルエントとなるように培地に播種した。CAフィルムP層とゼラチンファイバー層との二層基材の気液培養又は液内培養、及び、セルカルチャーインサートの気液培養又は液内培養の4条件で細胞培養した。なお、培養3日後で気液培養又は液内培養に移行させ、1~2日置きに培地交換を行った(各N=3)。
培養12日後(Day12)(各培養条件に移行して10日後)、及び21日後(Day21)(各培養条件に移行して19日後)の2時点でTEER値を測定した。本発明の透明二層基材はそのままでは市販のTEER装置に取り付けることが出来ないため、図14Aに示す3Dプリンターで独自に作製した測定用のチャンバー(上下に分割して二層基材を挟み込む)に取り付けた。このチャンバーは市販のTEER値測定用の電極を取り付ける空間も設けているため、Millipore社製の Millicell(登録商標) ERS-2 Epithelial Volt-0 hm Meterにテスト用電極 (MERSSTX04)とアジャスタブル電極(MERSSTX03)を取り付けて測定をおこなった。測定に際しては、二層基材の上下のチャンバーの空間は培養液で満たして測定をおこなった。
TEER値=(Rall-Rblank)×S
ここで、Rall:二層基材で細胞を培養した試料を用いての抵抗の測定値
Rblank:細胞を培養していない二層基材のみを用いての抵抗の測定値
S:有効培養面積。セルカルチャーインサート1.12 cm2、二層基材1 cm2であった。
図14BにN=3の実験値の平均値を示した。透明二層基材の気液界面培養で作製した腸管上皮組織モデルは、培養12日後(Day12)および培養21日後(Day21)では他の培養方法で作製した組織モデルよりも顕著に高いTEER値を示した。また、Caco-2をセルカルチャーインサートで培養して物質透過性アッセイに利用されている腸管上皮組織モデルのTEER値の文献値はおよそ110~850オーム平方センチメートル程度のものが報告されている(L.-F. Blume, et al., Pharmazie 65 (2010) 1, 19-24)。これらの値と比較しても、二層基材を用いて気液界面培養で作製した腸管上皮組織モデルは、顕著に高いTEER値を示した。
Claims (12)
- 湿潤条件下、光透過性を有する多孔性セルロース誘導体膜に高分子マイクロファイバーが紡糸され積層された、細胞及び/又は組織の培養用の透明二層基材。
- 前記培養が気液界面培養であることを特徴とする、請求項1に記載の透明二層基材。
- 前記細胞が腸管上皮細胞若しくは他の組織や器官の上皮細胞又は表皮を構成する細胞であり、前記組織が腸管上皮組織若しくは他の上皮組織又は表皮組織である、請求項1又は2に記載の透明二層基材。
- (1) セルロース誘導体を有機溶媒に溶解し、セルロース誘導体の有機溶媒溶液を調製するステップ、
(2) 前記セルロース誘導体の有機溶媒溶液を基板上にコーティングし、乾燥することによってセルロース誘導体膜を調製するステップ、
(3) 前記セルロース誘導体膜を所定の時間乾燥し、次に熱水に所定の時間浸漬し、次に冷水に所定の時間浸漬し、次に基板より剥離することにより、多孔性セルロース誘導体膜を調製するステップ、及び、
(4) エレクトロスピニング法によって、前記多孔性セルロース誘導体膜上に高分子マイクロファイバーを紡糸し、積層するステップ、
を含むことを特徴とする、細胞及び/又は組織の培養用の透明二層基材の製造方法。 - 請求項1に記載の透明二層基材を用い、高分子マイクロファイバー上で細胞及び/又は組織を培養することによって作製される生体組織モデル。
- 前記培養が気液界面培養であることを特徴とする請求項5に記載の生体組織モデル。
- 前記細胞が腸管上皮細胞若しくは他の組織や器官の上皮細胞又は表皮を構成する細胞であり、前記組織が腸管上皮組織若しくは他の上皮組織又は表皮組織であり、前記生体組織モデルが腸管上皮組織モデル若しくは他の上皮組織の組織モデル又は表皮組織モデルから選択されることを特徴とする、請求項5又は6に記載の生体組織モデル。
- 前記腸管上皮組織モデルが、絨毛突起構造、微絨毛構造、消化酵素活性、薬物代謝酵素活性、粘液産生能、バリア機能及び/又はアルカリホスファターゼ(ALP)の発現を有することを特徴とする、請求項7に記載の生体組織モデル。
- 請求項1に記載の透明二層基材を用い、高分子マイクロファイバー上で細胞及び/又は組織を培養することを特徴とする、生体組織モデルの作製方法。
- 前記培養が気液界面培養であることを特徴とする、請求項9に記載の生体組織モデルの作製方法。
- 前記細胞が腸管上皮細胞若しくは他の組織や器官の上皮細胞又は表皮を構成する細胞であり、前記組織が腸管上皮組織若しくは他の上皮組織又は表皮組織であり、前記生体組織モデルが、腸管上皮組織モデル若しくは他の上皮組織の組織モデル又は表皮組織モデルから選択されることを特徴とする、請求項9又は10に記載の生体組織モデルの作製方法。
- 前記腸管上皮組織モデルが、絨毛突起構造、微絨毛構造、消化酵素活性、薬物代謝酵素活性、粘液産生能、バリア機能及び/又はアルカリホスファターゼ(ALP)の発現を有することを特徴とする、請求項11に記載の生体組織モデルの作製方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2023525788A JPWO2022255251A1 (ja) | 2021-06-01 | 2022-05-27 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021092013 | 2021-06-01 | ||
JP2021-092013 | 2021-06-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022255251A1 true WO2022255251A1 (ja) | 2022-12-08 |
Family
ID=84324130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2022/021748 WO2022255251A1 (ja) | 2021-06-01 | 2022-05-27 | 二層培養基材 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPWO2022255251A1 (ja) |
WO (1) | WO2022255251A1 (ja) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03175973A (ja) * | 1989-09-26 | 1991-07-31 | Kirin Brewery Co Ltd | 動物細胞培養用担体およびその製造法 |
JPH0838165A (ja) * | 1994-04-25 | 1996-02-13 | Becton Dickinson & Co | 細胞培養基質およびその使用方法 |
JP2010502855A (ja) * | 2006-09-06 | 2010-01-28 | コーニング インコーポレイテッド | ナノファイバー、ナノフィルムおよびそれらの製造/使用方法 |
JP2017197874A (ja) * | 2016-04-27 | 2017-11-02 | パナソニックIpマネジメント株式会社 | 積層体、その製造方法および製造装置 |
JP2019162818A (ja) * | 2018-03-20 | 2019-09-26 | 旭化成株式会社 | 薄膜セルロース微細繊維積層シート |
-
2022
- 2022-05-27 WO PCT/JP2022/021748 patent/WO2022255251A1/ja active Application Filing
- 2022-05-27 JP JP2023525788A patent/JPWO2022255251A1/ja active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03175973A (ja) * | 1989-09-26 | 1991-07-31 | Kirin Brewery Co Ltd | 動物細胞培養用担体およびその製造法 |
JPH0838165A (ja) * | 1994-04-25 | 1996-02-13 | Becton Dickinson & Co | 細胞培養基質およびその使用方法 |
JP2010502855A (ja) * | 2006-09-06 | 2010-01-28 | コーニング インコーポレイテッド | ナノファイバー、ナノフィルムおよびそれらの製造/使用方法 |
JP2017197874A (ja) * | 2016-04-27 | 2017-11-02 | パナソニックIpマネジメント株式会社 | 積層体、その製造方法および製造装置 |
JP2019162818A (ja) * | 2018-03-20 | 2019-09-26 | 旭化成株式会社 | 薄膜セルロース微細繊維積層シート |
Also Published As
Publication number | Publication date |
---|---|
JPWO2022255251A1 (ja) | 2022-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Liu et al. | Silk fibroin as a biomaterial substrate for corneal epithelial cell sheet generation | |
Lawrence et al. | Silk film biomaterials for cornea tissue engineering | |
US10550366B2 (en) | Thermoresponsive cell culture supports | |
Chen et al. | Electrospun nanofibrous SF/P (LLA-CL) membrane: a potential substratum for endothelial keratoplasty | |
Lai et al. | Characterization of cross-linked porous gelatin carriers and their interaction with corneal endothelium: biopolymer concentration effect | |
Lin et al. | A new fish scale-derived scaffold for corneal regeneration | |
Higa et al. | Porous silk fibroin film as a transparent carrier for cultivated corneal epithelial sheets | |
Lovett et al. | Silk fibroin microtubes for blood vessel engineering | |
Sharma et al. | Surface-modified electrospun poly (ε-caprolactone) scaffold with improved optical transparency and bioactivity for damaged ocular surface reconstruction | |
US10988732B2 (en) | Graphene oxide-based porous 3D mesh | |
Yoo et al. | Use of elastic, porous, and ultrathin co‐culture membranes to control the endothelial barrier function via cell alignment | |
Wang et al. | Ductility and porosity of silk fibroin films by blending with glycerol/polyethylene glycol and adjusting the drying temperature | |
Lai | Influence of solvent composition on the performance of carbodiimide cross-linked gelatin carriers for retinal sheet delivery | |
Duval et al. | Organotypic culture to assess cell adhesion, growth and alignment of different organs on silk fibroin | |
JP2024051114A (ja) | 細胞培養用シート並びに三次元組織体及びその製造方法 | |
Li et al. | A biomimetic orthogonal-bilayer tubular scaffold for the co-culture of endothelial cells and smooth muscle cells | |
Nishiwaki et al. | In situ transplantation of adipose tissue‐derived stem cells organized on porous polymer nanosheets for murine skin defects | |
CN109248337A (zh) | 一种人工真皮修复材料及其制备方法 | |
Kopp et al. | Production and characterization of porous fibroin scaffolds for regenerative medical application | |
WO2022255251A1 (ja) | 二層培養基材 | |
Nithya et al. | Intelligent thermoresponsive substrate from modified overhead projection sheet as a tool for construction and support of cell sheets in vitro | |
Irani et al. | Oral mucosal epithelial cells grown on porous silicon membrane for transfer to the rat eye | |
US11414645B2 (en) | Thermoresponsive cell culture supports | |
Kianersi et al. | Mussel-inspired polydopamine-coated silk fibroin as a promising biomaterial | |
Kumar et al. | Native honeybee silk membrane: a potential matrix for tissue engineering and regenerative medicine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22816001 Country of ref document: EP Kind code of ref document: A1 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2023525788 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 18565425 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 22816001 Country of ref document: EP Kind code of ref document: A1 |